Bollard Group LLC Merck & Co., Inc. Transaction History

Bollard Group LLC

  • $3.76 Billion
  • Q3 2024

A detailed history of Bollard Group LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bollard Group LLC holds 184,479 shares of MRK stock, worth $18.1 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
184,479
Previous 184,306 0.09%
Holding current value
$18.1 Million
Previous $22.8 Million 8.19%
% of portfolio
0.56%
Previous 0.64%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$111.15 - $128.97 $19,228 - $22,311
173 Added 0.09%
184,479 $20.9 Million
Q2 2024

Aug 14, 2024
BUY
$123.8 - $132.96 $614,419 - $659,880
4,963 Added 2.77%
184,306 $22.8 Million
Q1 2024

May 13, 2024
BUY
$113.24 - $131.95 $119,354 - $139,075
1,054 Added 0.59%
179,343 $23.7 Million
Q4 2023

Feb 13, 2024
BUY
$100.18 - $109.02 $112,101 - $121,993
1,119 Added 0.63%
178,289 $19.4 Million
Q3 2023

Nov 14, 2023
BUY
$102.95 - $114.33 $105,729 - $117,416
1,027 Added 0.58%
177,170 $18.2 Million
Q2 2023

Aug 14, 2023
BUY
$108.61 - $118.38 $135,436 - $147,619
1,247 Added 0.71%
176,143 $20.3 Million
Q1 2023

May 12, 2023
BUY
$102.94 - $114.86 $616,610 - $688,011
5,990 Added 3.55%
174,896 $18.6 Million
Q4 2022

Feb 10, 2023
SELL
$87.44 - $112.11 $221,223 - $283,638
-2,530 Reduced 1.48%
168,906 $18.7 Million
Q3 2022

Nov 09, 2022
BUY
$84.53 - $94.96 $72,442 - $81,380
857 Added 0.5%
171,436 $14.8 Million
Q2 2022

Aug 12, 2022
BUY
$83.49 - $94.64 $104,612 - $118,583
1,253 Added 0.74%
170,579 $15.6 Million
Q1 2022

May 12, 2022
BUY
$73.51 - $82.4 $544,121 - $609,924
7,402 Added 4.57%
169,326 $13.9 Million
Q4 2021

Feb 11, 2022
BUY
$72.28 - $90.54 $26,382 - $33,047
365 Added 0.23%
161,924 $12.4 Million
Q3 2021

Nov 12, 2021
BUY
$71.68 - $78.83 $483,553 - $531,787
6,746 Added 4.36%
161,559 $12.1 Million
Q2 2021

Aug 12, 2021
BUY
$70.31 - $77.77 $730,239 - $807,719
10,386 Added 7.19%
154,813 $12 Million
Q1 2021

May 11, 2021
BUY
$68.86 - $81.11 $42,073 - $49,558
611 Added 0.42%
144,427 $11.1 Million
Q4 2020

Feb 04, 2021
SELL
$71.77 - $79.65 $254,855 - $282,837
-3,551 Reduced 2.41%
143,816 $11.8 Million
Q3 2020

Nov 12, 2020
BUY
$73.18 - $82.95 $1,244 - $1,410
17 Added 0.01%
147,367 $12.2 Million
Q2 2020

Aug 13, 2020
SELL
$70.42 - $80.13 $784,549 - $892,728
-11,141 Reduced 7.03%
147,350 $11.4 Million
Q1 2020

May 14, 2020
BUY
$63.36 - $87.82 $557,314 - $772,464
8,796 Added 5.88%
158,491 $12.2 Million
Q4 2019

Feb 10, 2020
BUY
$77.58 - $87.54 $68,115 - $76,860
878 Added 0.59%
149,695 $13.6 Million
Q3 2019

Nov 13, 2019
BUY
$76.08 - $82.93 $714,543 - $778,878
9,392 Added 6.74%
148,817 $12.5 Million
Q2 2019

Aug 13, 2019
BUY
$69.84 - $81.59 $826,835 - $965,944
11,839 Added 9.28%
139,425 $11.7 Million
Q1 2019

May 10, 2019
BUY
$69.58 - $79.36 $982,817 - $1.12 Million
14,125 Added 12.45%
127,586 $10.6 Million
Q4 2018

Feb 05, 2019
BUY
$65.24 - $75.71 $387,068 - $449,187
5,933 Added 5.52%
113,461 $8.67 Million
Q3 2018

Nov 08, 2018
BUY
$57.69 - $67.84 $386,465 - $454,460
6,699 Added 6.64%
107,528 $7.63 Million
Q2 2018

Aug 09, 2018
BUY
$50.83 - $59.72 $121,229 - $142,432
2,385 Added 2.42%
100,829 $6.12 Million
Q1 2018

May 14, 2018
BUY
$50.96 - $59.23 $346,171 - $402,349
6,793 Added 7.41%
98,444 $5.36 Million
Q4 2017

Jan 29, 2018
BUY
$51.62 - $61.64 $87,392 - $104,356
1,693 Added 1.88%
91,651 $5.16 Million
Q3 2017

Oct 27, 2017
BUY
$58.67 - $63.13 $5.28 Million - $5.68 Million
89,958
89,958 $5.76 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Bollard Group LLC Portfolio

Follow Bollard Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bollard Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bollard Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email